Mayo Clinic research set to launch aboard NASA mission to International Space Station to explore new therapies for bone loss
On Aug. 22, 2025, the Mayo Clinic announced that its pioneering exploration of stem cell-based therapies for bone…
Celltrion USA announces U.S. launch of denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo)
On Jul. 7, 2025, Celltrion announced that STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo), biosimilars referencing PROLIA® (denosumab) and XGEVA® (denosumab)…
Biotechnology | Disease | FDA | Oncology | Therapeutics | Women's Health
The FDA approved Eli Lilly and Company’s osteoporosis drug, Evista, to reduce the risk of invasive breast cancer
On Sept. 14, 2007, the U.S. Food and Drug Administration (FDA) announced it had approved Eli Lilly’s osteoporosis…
Texas Biomed researchers published a genetic linkage map for the rhesus monkey
In 2006, Texas Biomed researchers published a genetic linkage map for the rhesus monkey. In 1999, Texas Biomed…
World Osteoporosis Day established by the UK National Osteoporosis Society
Oct. 20, 1996, the United Kingdom’s National Osteoporosis Society supported by the European Commission, announced the creation of…
Diagnostics | Disease | NIH | Oncology | Therapeutics | Women's Health
Albert Einstein College becomes the only New York City medical school selected by the NIH to participate in the Women’s Health Initiative
In 1994, Albert Einstein College of Medicine becomes the only New York City medical school selected by the…
Biotechnology | Cardiovascular | Diagnostics | Disease | NIH | Oncology | Radiology | Therapeutics | Women's Health
The Women’s Health Initiative was launched
In 1991, the Women’s Health Initiative (WHI), sponsored by the National Heart, Lung, and Blood Institute (NHLBI), was…